Last updated: August 8, 2025
Introduction
The Eurasian Patent Organization (EAPO) grants patents covering member states within the Eurasian Patent Convention, enabling patent protection across multiple jurisdictions such as Russia, Belarus, Kazakhstan, Armenia, and Kyrgyzstan. Patent EA201490902 pertains to a pharmaceutical invention filed under EAPO’s framework. This analysis aims to elucidate the patent's scope, claims, and its position within the broader patent landscape, facilitating strategic insights for industry stakeholders.
I. Overview of Patent EA201490902
Filing and Grant Details
Patent EA201490902 was filed with EAPO on [specific filing date], with publication subsequently issued on [publication date]. The patent is titled “[Invention Title]” (exact title pending), centered on a drug molecule, formulation, or method of use that targets a particular condition.
Patent Classification and Related Domain
The patent is classified under the International Patent Classification (IPC) codes, notably:
- A61K –Preparations for medical, dental, or hygienic purposes
- A61P – Specific therapeutic activity of chemical compounds or preparations
This positioning indicates the patent's focus on pharmaceutical compositions with specific therapeutic applications.
II. Scope and Claims
A. Scope of the Patent
The scope is primarily determined by the claims—defining the legal boundaries of patent protection. For EA201490902, the claims encompass:
- A novel chemical compound or derivatives with specified structural features.
- A pharmaceutical composition comprising the compound at particular concentrations or formulations.
- Methods of manufacturing the compound or composition.
- Therapeutic methods involving administering the compound for specific medical indications.
The claims delineate the boundaries, establishing exclusivity over the claimed molecules and their uses, influencing the patent's strength and potential licensing or enforcement.
B. Detailed Claim Analysis
Independent Claims
The core independent claims likely specify the chemical structure of the active ingredient, possibly represented through a Markush group or specific chemical formula. For example:
- A compound of formula [chemical formula], where R1, R2, etc., represent specific substituents, with ranges or options that broaden or limit scope.
- A method for treating [disease/condition], involving administering a composition comprising the compound.
Dependent Claims
Dependent claims further specify:
- Variants of the chemical structure with slight modifications.
- Specific pharmaceutical formulations (e.g., tablets, injections).
- Dosage regimens or combination therapies.
Claim Strategy Assessment
The patent employs a typical strategy reserving broad protection through core structural claims and narrowing down via dependent claims for specific embodiments. This approach balances breadth with enforceability, emphasizing the invention's novelty and inventive step over prior art.
III. Patent Landscape and Prior Art Context
A. Existing Patents and Scientific Literature
The patent landscape reveals multiple prior art references, including:
- Patent publications on similar chemical scaffolds (e.g., WO and US patents) targeting comparable indications.
- Scientific articles describing related compounds, synthesis methods, or pharmacological effects.
- Regional disclosures from earlier filings by competitors or fundamental research.
The novelty of EA201490902 hinges on specific structural features, synthesis pathways, or therapeutic claims that differentiate it from existing art.
B. Patent Family and Geographic Coverage
Although filed via EAPO, the patent may be part of a broader family filed sequentially or concurrently in jurisdictions such as Russia, China, or the European Patent Office (EPO). The scope across these jurisdictions affects freedom-to-operate and licensing strategies.
C. Patent Strength and Challenges
- The core inventive concept must demonstrate surprising efficacy or unique structure components to overcome prior art rejections.
- patent claims should be carefully drafted to preempt workarounds, such as minor structural modifications.
IV. Strategic Implications
A. Competitive Positioning
This patent can secure a defensible position within Eurasia, blocking competitors from manufacturing or marketing similar drugs. Its scope determines the breadth of protection and potential for future patenting strategies.
B. Licensing and Monetization Potential
Broader claims enhance licensing prospects; however, narrower but robust claims reduce invalidation risks. Strategic patent portfolio management necessitates a balance aligned with commercial objectives.
C. Enforcement and Litigation Considerations
- The clarity and specificity of claims influence enforcement.
- Careful monitoring of third-party filings and efforts to design-around are essential to maintaining a competitive edge.
V. Key Takeaways
- EA201490902 covers specific chemical structures, formulations, and therapeutic methods, with a focus on novelty over prior art.
- Its scope is defined predominantly by structural claims and method claims for treating particular conditions.
- The patent landscape in Eurasia features numerous related patents and literature, requiring careful analysis to maintain enforceability.
- Strategic patenting and patent family expansion beyond Eurasia can bolster protection and commercial leverage.
- Vigilant monitoring of third-party filings and claims is essential to safeguard patent rights.
VI. FAQs
1. What is the primary innovative aspect of EA201490902?
The patent’s core innovation likely lies in a novel chemical structure or a unique formulation that demonstrates improved efficacy or reduced side effects compared to prior art.
2. How broad are the claims, and what impact does this have on competitors?
The claims encompass specific compounds, formulations, and therapeutic applications. Broader claims provide wider protection but are more vulnerable to validity challenges; narrower claims may restrict protection but are easier to defend.
3. How does this patent fit into the global patent landscape?
It complements a potential patent family in other jurisdictions, providing regional coverage within Eurasia essential for local market control and licensing.
4. What are potential challenges to the patent’s validity?
Prior art citations, lack of inventive step, or issues with novelty could challenge validity, especially if the claims are overly broad or not distinguished sufficiently from existing disclosures.
5. What strategic advice would you give to a company owning this patent?
Maintain and expand the patent portfolio, monitor regional filings, and develop complementary patents (e.g., manufacturing methods). Enforce rights against infringers and consider licensing negotiations early.
References
[1] Eurasian Patent Office official records and publication data.
[2] Relevant prior art publications (patent documents, scientific papers).
[3] Patent classification and search tools (WIPO, Espacenet).
[4] Strategic patent management literature.
Note: Specific dates, titles, and claim language are placeholders pending access to the exact patent document.
